These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31897329)

  • 1. Prognostic Role of
    Hwang KT; Kim BH; Oh S; Park SY; Jung J; Kim J; Choi IS; Jeon SY; Kim WY
    J Breast Cancer; 2019 Dec; 22(4):548-561. PubMed ID: 31897329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value and Clinical Significance of LIPH in Breast Cancer.
    Gao P; Liu Q; Ai B; Fang Y; Wang Z; Wang J
    Int J Gen Med; 2021; 14():7613-7623. PubMed ID: 34754232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
    Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
    Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
    [No Abstract]   [Full Text] [Related]  

  • 4. The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.
    Guo L; Chen B; Zhang G; Wang Y; Cao L; Ren C; Wen L; Lin J; Wei G; Liao N
    Gene; 2020 Oct; 759():144970. PubMed ID: 32711101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer.
    Vollan HK; Rueda OM; Chin SF; Curtis C; Turashvili G; Shah S; Lingjærde OC; Yuan Y; Ng CK; Dunning MJ; Dicks E; Provenzano E; Sammut S; McKinney S; Ellis IO; Pinder S; Purushotham A; Murphy LC; Kristensen VN; ; Brenton JD; Pharoah PD; Børresen-Dale AL; Aparicio S; Caldas C
    Mol Oncol; 2015 Jan; 9(1):115-27. PubMed ID: 25169931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
    Tokumaru Y; Oshi M; Katsuta E; Yan L; Satyananda V; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
    Am J Cancer Res; 2020; 10(3):897-907. PubMed ID: 32266098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
    Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
    BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL2 Regulation according to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database.
    Hwang KT; Kim K; Chang JH; Oh S; Kim YA; Lee JY; Jung SH; Choi IS
    Cancer Res Treat; 2018 Jul; 50(3):658-669. PubMed ID: 28701032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers.
    Willis S; Sun Y; Abramovitz M; Fei T; Young B; Lin X; Ni M; Achua J; Regan MM; Gray KP; Gray R; Wang V; Long B; Kammler R; Sparano JA; Williams C; Goldstein LJ; Salgado R; Loi S; Pruneri G; Viale G; Brown M; Leyland-Jones B
    JCO Precis Oncol; 2017; 1():. PubMed ID: 32913979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between histone lysine methyltransferase KMT2C mutation and clinicopathological factors in breast cancer.
    Chen X; Zhang G; Chen B; Wang Y; Guo L; Cao L; Ren C; Wen L; Liao N
    Biomed Pharmacother; 2019 Aug; 116():108997. PubMed ID: 31146111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High miR-99b expression is associated with cell proliferation and worse patient outcomes in breast cancer.
    Oshi M; Tokumaru Y; Benesch MG; Sugito N; Wu R; Yan L; Yamada A; Chishima T; Ishikawa T; Endo I; Takabe K
    Am J Cancer Res; 2022; 12(10):4840-4852. PubMed ID: 36381329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.
    Kurozumi S; Joseph C; Sonbul S; Aleskandarany MA; Pigera M; Alsaleem M; Alsaeed S; Kariri Y; Nolan CC; Diez-Rodriguez M; Johnston S; Mongan NP; Fujii T; Shirabe K; Martin SG; Ellis IO; Green AR; Rakha EA
    Breast Cancer Res Treat; 2018 Nov; 172(1):61-68. PubMed ID: 30056565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutaminase (GLS1) gene expression in primary breast cancer.
    Vidula N; Yau C; Rugo HS
    Breast Cancer; 2023 Nov; 30(6):1079-1084. PubMed ID: 37679553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies.
    Carene D; Tran-Dien A; Lemonnier J; Dalenc F; Levy C; Pierga JY; Jacot W; Canon JL; Richon C; Lacroix L; Caux C; André F; Michiels S
    Breast Cancer Res Treat; 2020 Jan; 179(2):387-401. PubMed ID: 31620934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (-) Breast Cancer.
    Du F; Zheng F; Han Y; Zhao J; Yuan P
    Front Pharmacol; 2022; 13():820437. PubMed ID: 35721151
    [No Abstract]   [Full Text] [Related]  

  • 16. Classification of HER2-negative breast cancers by
    Loh JW; Lim AH; Chan JY; Yap YS
    Ther Adv Med Oncol; 2023; 15():17588359231206259. PubMed ID: 37920257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Analysis of Somatic Copy Number Alteration Burden With Breast Cancer Survival.
    Zhang L; Feizi N; Chi C; Hu P
    Front Genet; 2018; 9():421. PubMed ID: 30337938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival outcomes are associated with genomic instability in luminal breast cancers.
    King L; Flaus A; Holian E; Golden A
    PLoS One; 2021; 16(2):e0245042. PubMed ID: 33534788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of
    Li C; Zhang G; Wang Y; Chen B; Li K; Cao L; Ren C; Wen L; Jia M; Mok H; Lai J; Xiao W; Li X; Liao N
    Oncol Lett; 2022 Feb; 23(2):68. PubMed ID: 35069877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer.
    Karn T; Jiang T; Hatzis C; Sänger N; El-Balat A; Rody A; Holtrich U; Becker S; Bianchini G; Pusztai L
    JAMA Oncol; 2017 Dec; 3(12):1707-1711. PubMed ID: 28750120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.